Literature DB >> 8730720

Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal [corrected].

D S Rohde1, D J Detweiler, A I Basbaum.   

Abstract

Tolerance to the analgesic effects of morphine results in part from the development of a compensatory response in neurons that express the opioid receptor or of neural circuits in which those neurons participate. According to this formulation, withdrawal of morphine results in an overshoot of several neuronal properties because of the unopposed action of the compensatory response system. To identify the population of spinal cord neurons that underlies this state, we monitored expression of Fos-like immunoreactivity, after naltrexone-precipitated abstinence in normal and morphine-tolerant rats. After daily (five days) implantation of morphine or placebo pellets, the rats received an injection of saline or naltrexone and behavior was monitored for 1 h. The rats were then killed, their spinal cords removed and 50-microns transverse sections of the lumbar cord were immunostained with a rabbit polyclonal antiserum directed against Fos. Naltrexone injection in the placebo group did not increase spinal cord Fos expression. Naltrexone-precipitated abstinence resulted in an increase in Fos expression at all levels of the spinal cord; the greatest increase and densest staining was in laminae I through VI. Importantly, when withdrawal was precipitated in anesthetized rats, we recorded a significant reduction in Fos expression, particularly in laminae III through VI, but there was persistent expression in the superficial dorsal horn, particularly in lamina I. These results suggest that spinal cord nociresponsive neurons are sensitized during the development of tolerance. This sensitization is unmasked by the administration of naltrexone and is manifested by fos induction in laminae I/II in awake or anesthetized withdrawing animals. The underlying mechanisms of tolerance development may be similar to those that underlie injury-induced central sensitization and hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730720     DOI: 10.1016/0306-4522(95)00529-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

Review 1.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

Review 2.  Responsible prescribing of opioids for the management of chronic pain.

Authors:  Bruce Nicholson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat.

Authors:  D S Rohde; A I Basbaum
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

4.  The role of spinal neuropeptides and prostaglandins in opioid physical dependence.

Authors:  Tuan Trang; Maaja Sutak; Remi Quirion; Khem Jhamandas
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal.

Authors:  Tuan Trang; Maaja Sutak; Remi Quirion; Khem Jhamandas
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

6.  The Development of a Macromolecular Analgesic for Arthritic Pain.

Authors:  Laura Weber; Xiaobei Wang; Rongguo Ren; Xin Wei; Gang Zhao; Junxiao Yang; Hongjiang Yuan; Huiling Pang; Hanjun Wang; Dong Wang
Journal:  Mol Pharm       Date:  2019-02-14       Impact factor: 4.939

7.  Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.

Authors:  Anika A McPhie; Gordon A Barr
Journal:  Dev Psychobiol       Date:  2009-11       Impact factor: 3.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.